MorphoSys stock tumbles 24% post-market amid Phase 3 data (update)
Post Content
Similar Posts
World at risk of losing malaria fight as cases rise, report says
Post Content Post Views: 138
Labor group seeks three board seats at Starbucks – sources
Post Content Post Views: 157
Bank of Korea to hold rates at 3.50% until at least mid-2024: Reuters poll
Post Content Post Views: 138
India stocks set to hit new highs in 2024 as economy hums
Post Content Post Views: 155
US asks Israel to narrow zone of combat in any southern Gaza attack
Post Content Post Views: 139
Citigroup’s municipal-bond team joins Jefferies amid restructuring – Bloomberg
Post Content Post Views: 129